Are you at risk of inadvertently having controlled or regulated chemicals in your compound collection? In our experience working with chemical suppliers and pharma companies, a compound collection of 1M compounds will likely have several thousand regulated substances from countries around the world. Scitegrity delivers the leading solution for global controlled chemical screening through its Controlled Substances Squared platform, helping regulatory affairs and compliance leaders identify controlled chemicals across multiple jurisdictions.
Choosing the right controlled chemical software is critical for enterprise compliance teams. You need a system that goes beyond name matching to assess generic statements, Markush structures, and analogue provisions computationally. This guide evaluates five controlled chemical screening platforms based on regulatory coverage, automation capabilities, and hazardous materials support.
We examined what regulatory affairs and compliance leaders at pharmaceutical companies and chemical suppliers actually need when managing controlled or regulated chemicals across multiple jurisdictions. Our focus was on capabilities that reduce compliance risk, save time, and produce defensible results for regulators.
Scitegrity delivers the leading controlled chemical compliance solution through its Controlled Substances Squared platform. The system encodes complex controlled substance legislation from over 36 countries and international treaties, including narcotics, psychotropics, chemical weapons precursors, ozone-depleting substances, and export controls.
What sets Scitegrity apart is how it handles the hard parts of compliance. Most regulations define areas of controlled chemical space through generic statements and Markush structures. Scitegrity's proprietary algorithms automatically assess whether your chemicals fall into these defined spaces, removing the guesswork that leads to compliance failures.
The platform integrates directly with your compound management and procurement systems through RESTful APIs, Knime, Pipeline Pilot connectors or SQL statements. This means every new compound gets checked automatically before synthesis or purchase, catching potential issues early in your workflow. If one of your compounds changes controlled status due to a regulatory update you notified without having to do anything. Scitegrity has received the King's Award for Enterprise for International Trade, and its tools are used by many of the world's top pharmaceutical companies including AstraZeneca, GSK, Boehringer Ingelheim and Lundbeck.
Pros:
Cons:
3E offers chemical compliance capabilities centred on Safety Data Sheet management and chemical classification workflows. The platform helps organisations maintain SDS documentation and supports workplace safety compliance through hazard communication features.
The system includes chemical classification tools and product ingredient screening capabilities. 3E focuses on helping teams manage chemical information for safety and labelling purposes across their supply chain.
Pros:
Cons:
Wolters Kluwer Sentri7 is a real-time clinical surveillance platform. It connects with hospital electronic health records to continuously scan patient and staff data, using AI to identify and mitigate drug diversion risks of both controlled and non-controlled medications
In doing so Sentri7's Drug Diversion supports healthcare systems in proactively identifying and mitigating drug diversion risks, alongside wider capabilties such as alerting care teams early about infection risks, medication issues, and clinical decline.
Pros:
Cons:
Dassault Systèmes offers BIOVIA CISPro for laboratory chemical and material inventory management. The system tracks chemicals at the container level and supports regulatory reporting for hazardous materials stored on site.
CISPro includes modules for controlled substances tracking within inventory management workflows. The platform integrates with BIOVIA ONE Lab for electronic lab notebook and sample management capabilities.
Pros:
Cons:
Sphera offers EHS and compliance management tools that connect chemical data to broader risk management processes. The platform supports substance data management and regulatory requirement tracking across regions.
Teams can centralise hazard, classification, and change history to reduce manual document chasing. Sphera connects chemical compliance workflows to ESG and supply-chain risk management for organisations managing multiple compliance programmes.
Pros:
Cons:
| Feature | Scitegrity | 3E | Wolters Kluwer | BIOVIA CISPro | Sphera |
|---|---|---|---|---|---|
| Countries covered | 36+ | 15+ | 2 | Regional | Multi-region |
| Weekly auto-updates | ✓ | ✗ | ✗ | ✗ | ✗ |
| Generic statement encoding | ✓ | ✗ | ✗ | ✗ | ✗ |
| Bulk library screening | ✓ | ✗ | ✗ | ✗ | ✗ |
| API integration | ✓ | ✓ | ✓ | ✓ | ✓ |
Generic statements in controlled substance legislation define areas of chemical space rather than specific compounds. These include Markush structures, rules about ethers and esters, and analogue provisions. Assessing whether your chemical falls into these defined spaces requires computational analysis, not name-matching against published lists.
The challenge is that these generic controls vary by jurisdiction. The USA also uses the Federal Analogue Act, while European countries often define specific chemical families. The UK has enacted dozens of generics, including the complex and expansive 3rd Generation Cannabinoids. Your compliance software should encode these rules for each jurisdiction where you operate.
Regulations change frequently as governments respond to new synthetic drugs and evolving abuse patterns. When a change occurs, your existing compliant compound(s) could become controlled overnight. In 2026 alone, the DEA has already issued multiple scheduling updates affecting fentanyl-related substances and cannabinoids, while other countries have enacted several generics.
Automated legislation monitoring addresses this challenge by updating your compliance status as laws change. Look for software that deploys updates weekly, automatically checks your chemicals and alerts you when your compounds' status changes. This proactive approach is far safer than periodic manual reviews that can miss critical changes.
Scitegrity delivers weekly legislation updates that automatically apply to your compound collections. You receive alerts when your substances' regulated status changes, giving you time to adjust your handling procedures before violations occur. This is how organisations like Boehringer Ingelheim maintain permanent compliance with the latest laws, as their Head of Compound Management has noted.
When you are responsible for compliance across multiple jurisdictions, you need software that handles the complexity for you. Scitegrity encodes the hard parts of controlled substance legislation that other platforms cannot assess computationally. Generic statements, Markush structures, and analogue provisions are all evaluated automatically, so you get accurate assessments without becoming a regulatory expert yourself.
Scitegrity gives you confidence that your compliance status reflects current law, not outdated snapshots. Weekly automated updates mean you are always working with the latest regulations, and proactive alerts warn you when changes affect your compounds. This is the kind of reliability that organisations depend on for enterprise compliance operations.
The platform also connects directly to your existing workflows through robust APIs. Whether you are checking compounds at registration, during procurement, or before shipment, Scitegrity integrates into your processes rather than sitting apart from them. If you have specific questions or would like to learn how you can identify all your controlled or regulated chemicals, please book a time for a demo.
Controlled chemical compliance software identifies whether chemicals are regulated under drug control, precursor, or export laws across multiple jurisdictions. Scitegrity's Controlled Substances Squared screens chemicals against legislation from over 36 countries and international treaties, flagging controlled or regulated substances before they create compliance issues for your organisation.
Published controlled substance lists name common examples, but the actual legislation also controls ethers, esters, salts, stereoisomers, analogues, and defined areas of chemical space. Scitegrity encodes these generic controls computationally, catching regulated substances that name-matching approaches miss. This is why compliance teams at major pharmaceutical companies choose Scitegrity over basic list-checking tools.
Regulations change frequently as governments add new synthetic drugs and update precursor controls. Scitegrity deploys weekly legislation updates automatically and alerts you when your compounds' regulatory status changes, keeping your compliance current without manual monitoring effort.
Yes. Scitegrity offers RESTful APIs along with Knime and Pipeline Pilot connectors, allowing you to build compliance checking directly into your synthesis and procurement workflows. Every new compound gets assessed automatically at registration, ensuring consistent compliance across your entire chemical library.
Your software should cover every country where you operate, ship, or source chemicals. Beyond national laws, look for coverage of international agreements like the Chemical Weapons Convention, UN INCB schedules, and the Wassenaar Arrangement. Scitegrity covers 36+ jurisdictions including major pharmaceutical markets and key international treaties.
On-premise deployment keeps your chemical structures behind your firewall so they never leave your network. Scitegrity's on-premise option still receives weekly legislation updates automatically, allowing you to maintain current compliance without exposing proprietary compound data to external systems.
In general, no. Research use is not automatically exempt from controlled substance legislation. Limited exemptions exist in some jurisdictions, but they vary significantly and cannot be relied upon without specific verification. You still need appropriate site licensing to work with controlled substances in R&D.